Tyrosine phosphorylation controls PCNA function through protein stability

Nature Cell Biology

Volumn 8, Issue 12, 2006, Pages 1359-1368

  Wang, Shao Chun ^a   Nakajima, Yusuke ^a,b   Yu, Yung Luen ^a   Xia, Weiya ^a   Chen, Chun Te ^a,c   Yang, Cheng Chieh ^a,c   McIntush, Eric W ^d   Li, Long Yuan ^a,e   Hawke, David H ^a   Kobayashi, Ryuji ^a   Hung, Mien Chie ^a,c,e  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c UNIVERSITY OF TEXAS   (United States)

^d Bethyl Laboratories Inc   (United States)

^e CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; TYROSINE; TYROSINE KINASE RECEPTOR;

ARTICLE; BREAST CANCER; CANCER SURVIVAL; CELL NUCLEUS; CELL PROLIFERATION; CHROMATIN; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY;

CELL NUCLEUS; CELL PROLIFERATION; CHROMATIN; DNA REPAIR; DNA REPLICATION; HELA CELLS; HUMANS; PHOSPHORYLATION; PHOSPHOTYROSINE; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN BINDING; RECEPTOR, EPIDERMAL GROWTH FACTOR; THERMODYNAMICS;

EID: 33751508862     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncb1501     Document Type: Article

References (48)

1. Kelman, Z. & O'Donnell, M. Structural and functional similarities of prokaryotic and eukaryotic DNA polymerase sliding clamps. Nucleic Acids Res. 23, 3613-3620 (1995).
2. Bravo, R. & Macdonald-Bravo, H. Existence of two populations of cyclin/ proliferating cell nuclear antigen during the cell cycle: Association with DNA replication sites. J. Cell Biol. 105, 1549-1554 (1987).
3. Paunesku, T. et al. Proliferating cell nuclear antigen (PCNA): ringmaster of the genome. Int. J. Radiat. Biol. 77, 1007-1021 (2001).
4. Haracska, L., Torres-Ramos, C.A., Johnson, R.E., Prakash, S. & Prakash, L. Opposing effects of ubiquitin conjugation and SUMO modification of PCNA on replicational bypass of DNA lesions in Saccharomyces cerevisiae. Mol. Cell. Biol. 24, 4267-4274 (2004).
5. Kannouche, P.L. & Lehmann, A.R. Ubiquitination of PCNA and the polymerase switch in human cells. Cell Cycle 3, 1011-1013 (2004).
6. Jonsson, Z.O., Podust, V.N., Podust, L.M. & Hubscher, U. Tyrosine 114 is essential for the trimeric structure and the functional activities of human proliferating cell nuclear antigen. EMBO J. 14, 5745-5751 (1995).
7. Maga, G. & Hubscher, U. Proliferating cell nuclear antigen (PCNA): A dancer with many partners. J. Cell Sci. 116, 3051-3060 (2003).
8. Yarden, Y. & Sliwkowski, M.X. Untangling the ErbB signalling network. Nature Rev. Mol. Cell Biol. 2, 127-137 (2001).
9. Lin, S.Y. et al. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nature Cell Biol. 3, 802-808 (2001).
10. Lo, H.-W. et al. Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. Cancer Cell 7, 575-589 (2005).
11. Hanada, N. et al. Co-regulation of b-Myb expression by E2F1 and EGF receptor. Mol. Carcinog. 45, 10-17 (2006).
12. Assy, N. & Minuk, G.Y. Liver regeneration: Methods for monitoring and their applications. J. Hepatol. 26, 945-952 (1997).
13. Marti, U. & Hug, M. Acinar and cellular distribution and mRNA expression of the epidermal growth factor receptor are changed during liver regeneration. J. Hepatol. 23, 318-327 (1995).
14. Psyrri, A. et al. Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis. Clin. Cancer Res. 11, 5856-5862 (2005).
15. Marti, U. et al. Nuclear localization of epidermal growth factor and epidermal growth factor receptors in human thyroid tissues. Thyroid 11, 137-145 (2001).
16. Tao, Y. et al. Nuclear accumulation of epidermal growth factor receptor and acceleration of G1/S stage by Epstein-Barr-encoded oncoprotein latent membrane protein 1. Exp. Cell Res. 303, 240-251 (2005).
17. Lo, H.-W. et al. Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer. Cancer Res. 65, 338-348 (2005).
18. Jeziorski, A., Blonski, J.Z. & Niewiadomska, H. The expression of products of oncogens c-erbB2 and EGFR and proliferating antigens Ki67 and PCNA in primary invasive ductal cancer of female breast. J. Exp. Clin. Cancer Res. 19, 61-67 (2000).
19. Shrestha, P. et al. Proliferating cell nuclear antigen in breast lesions: Correlation of cerbB-2 oncoprotein and EGF receptor and its clinicopathological significance in breast cancer. Virchows Arch. A Pathol. Anat. Histopathol. 421, 193-202 (1992).
20. Frassoldati, A. et al. Changes of biological features in breast cancer cells determined by primary chemotherapy. Breast Cancer Res. Treat. 44, 185-192 (1997).
21. Hoege, C., Pfander, B., Moldovan, G.-L., Pyrowolakis, G. & Jentsch, S. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 419, 135-141 (2002).
22. Stelter, P. & Ulrich, H.D. Control of spontaneous and damage-induced mutagenesis by SUMO and ubiquitin conjugation. Nature 425, 188-191 (2003).
23. Ulrich, H.D. How to activate a damage-tolerant polymerase: Consequences of PCNA modifications by ubiquitin and SUMO. Cell Cycle 3, 15-18 (2004).
24. Kiyokawa, N., Lee, E.K., Karunagaran, D., Lin, S.-Y. & Hung, M.-C. Mitosis-specific negative regulation of epidermal growth factor receptor, triggered by a decrease in ligand binding and dimerization, can be overcome by overexpression of receptor. J. Biol. Chem. 272, 18656-18665 (1997).
25. Ammosova, T. et al. Nuclear targeting of protein phosphatase-1 by HIV-1 Tat protein. J. Biol. Chem. 280, 36364-36371 (2005).
26. Hasan, S., Hassa, P.O., Imhof, R. & Hottiger, M.O. Transcription coactivator p300 binds PCNA and may have a role in DNA repair synthesis. Nature 410, 387-391 (2001).
27. Umar, A. et al. Requirement for PCNA in DNA mismatch repair at a step preceding DNA resynthesis. Cell 87, 65-73 (1996).
28. Kato, T. et al. New prognostic factors associated with long-term survival in node-negative breast cancer patients. Breast Cancer 6, 370-377 (1999).
29. Kato, T., Kameoka, S., Kimura, T., Nishikawa, T. & Kobayashi, M. The combination of angiogenesis and blood vessel invasion as a prognostic indicator in primary breast cancer. Br. J. Cancer 88, 1900-1908 (2003).
30. Lee, J.S. et al. Correlation between angiogenesis, apoptosis and cell proliferation in invasive ductal carcinoma of the breast and their relation to tumor behavior. Anal. Quant. Cytol. Histol. 23, 161-168 (2001).
31. Bukholm, I.R.K., Bukholm, G., Holm, R. & Nesland, J.M. Association between histology grade, expression of HsMCM2, and cyclin A in human invasive breast carcinomas. J. Clin. Pathol. 56, 368-373 (2003).
32. Grossi, F. et al. Prognostic significance of K-ras, p53, bcl-2, PCNA, CD34 in radically resected non-small cell lung cancers. Eur. J. Cancer 39, 1242-1250 (2003).
33. Heimann, R., Ferguson, D., Recant, W.M. & Hellman, S. Breast cancer metastatic phenotype as predicted by histologic tumor markers. Cancer J. Sci. Am. 3, 224-249 (1997).
34. Arteaga, C.L. Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasia. Semin. Oncol. 29, 3-9 (2002).
35. Baselga, J. Why the epidermal growth factor receptor? The rationale for cancer therapy. Oncologist 7, 2-8 (2002).
36. Wang, S.-C. et al. Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2. Cancer Cell 6, 251-261 (2004).
37. Xie, Y.M. & Hung, M.C. Nuclear localization of p185neu tyrosine kinase and its association with transcriptional transactivation. Biochem. Biophys. Res. Commun. 203, 1589-1598 (1994).
38. Offterdinger, M., Schofer, C., Weipoltshammer, K. & Grunt, T.W. c-erbB-3: A nuclear protein in mammary epithelial cells. J. Cell Biol. 157, 929-940 (2002).
39. Ni, C.-Y., Murphy, M.P., Golde, T.E. & Carpenter, G. γ-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 294, 2179-2181 (2001).
40. Lo, H.W. & Hung, M.C. Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival. Br. J. Cancer 94, 184-188 (2006).
41. Massie, C. & Mills, I.G. The developing role of receptors and adaptors. Nature Rev. Cancer 6, 403-409 (2006).
42. Carpenter, G. Nuclear localization and possible functions of receptor tyrosine kinases. Curr. Opin. Cell Biol. 15, 143-148 (2003).
43. Wells, A. & Marti, U. Signalling shortcut: Cell-surface receptors in the nucleus? Nature Rev. Mol. Cell Biol. 3, 697-702 (2002).
44. Lo, H.W. et al. Nuclear-cytoplasmic transport of EGFR involves receptor endocytosis, importin β1 and CRM1. J. Cell Biochem. 98, 1570-1583 (2006).
45. Giri, D.K. et al. Endosomal transport of ErbB-2: A mechanism for nuclear entry of cell surface receptor. Mol. Cell. Biol. 25, 11005-11018 (2005).
46. Williams, C.C. et al. The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone. J. Cell Biol. 167, 469-478 (2004).
47. Huang, T.T. et al. Regulation of monoubiquitinated PCNA by DUB autocleavage. Nature Cell Biol. 8, 341-347 (2006).
48. Asada, M. et al. Apoptosis inhibitory activity of cytoplasmic p21(Cip1/ WAF1) in monocytic differentiation. EMBO J. 18, 1223-1234 (1999).